M. Breyer (Vienna, Austria), W. Karrer (Crans-Montana, Switzerland)
Late Breaking Abstract: Vitamin D deficiency linked to sepsis in COPD with acute infective exacerbations
D. Talwar, A. Goel, S. Joshi, V. Mishra, S. Kumar (Noida, India)
|  |
Systemic inflammation in chronic obstructive pulmonary disease in patients with pulmonary hypertension
A. Komlev, A. Kuziaev, L. Soboleva, G. Laskin (St. Petersberg, Russian Federation)
| |
Influence of bacterial colonization (BC) on the level of systemic inflammatory markers (SIM) in COPD patients (pts)
T. Pertseva, L. Konopkina (Dnepropetrovsk, Ukraine)
|  |
Association between airway inflammation and systemic inflammation in stable chronic obstructive pulmonary disease
X. He (Beijing, China)
| |
Human β-defensin 2 and interleukin-8 as potential serum markers of pulmonary emphysema
T. Hamada, T. Samukawa, G. Tsukuya, K. Ohara, M. Soejima, H. Nagahama, K. Oketani, H. Tsubouchi (Kagoshima, Japan)
| |
Analysis of semi-volatile organic compounds in exhaled breath condensate of patients with obstructive lung diseases
E. Anaev, T. Anokhina, A. Rodionov, A. Revelsky, I. Revelsky, D. Alexeev, V. Kudriavtsev, A. Chuchalin (Moscow, Russian Federation)
| |
The Importance of the local expression of acute phase reactants in the COPD
B. Rojano, C. Calero, F. J. Saenz, M. López-Porras, E. Arellano, A. Blanco, J. L. Lopez-Campos (Seville, Spain)
| |
Is CRP really valid acute-phase inflammation reactant in all patients with sputum bacterial positive culture in acute exacerbation of COPD?
L. Ristic, M. Radovic, I. Stankovic, T. Pejcic (Nis, Republic Of Serbia)
| |
LSC 2010 Abstract: Synthetic dsRNA exacerbates pulmonary inflammation in acute and sub-chronic in vivo models of COPD
R. U. Schäfer, G. Jung (Biberach/Riss, Germany)
| |
The effects of anxiety and depression on treatment adherence in COPD patients
O. Turan, B. Yemez, O. Itil (Izmir, Turkey)
| |
Correlation between vitamin D and bone mineral density in COPD
E. A. P. M. Romme, E. Rutten, F. Smeenk, M. A. Spruit, T. Hofstra, P. Menheere, E. F. M. Wouters (Eindhoven, Horn, Maastricht, Netherlands)
| |
Circulating vascular endothelial growth factor and osteoporosis in patients with COPD
E. Kochetkova, U. Maistrovskay, K. Buria, R. Kessler, G. Massard (Vladivostok, Russian Federation; Strasbourg, France)
| |
Bone mineral density is related to exercise capacity in COPD
T. Matsuda, H. Taniguchi, Y. Kondoh, T. Kimura, K. Kataoka, S. Taga, O. Nishiyama, T. Ogawa, F. Watanabe, S. Arizono (Seto, Osaka-Sayama, Japan)
| |
Structure-functional bone mineral status in rats with induced bronchitis
N. Masik (Vinnitsa, Ukraine)
| |
Correlates of osteoporosis in chronic obstructive pulmonary disease (COPD)
T. Przybylowski, J. Nasilowski, R. Rubinsztajna, K. Karwat, Z. Bartoszewicz, J. Przedlacki, K. Hildebrand, R. Chazan (Poland)
| |
Gender-specific differences in symptoms among patients with severe COPD
M. Cazzola, M. Miravitlles, C. Vogelmeier, M. Partridge, D. Leynaud, J. Ostinelli, R. Kessler (Rome, Italy; Barcelona, Spain; Marburg, Germany; London, United Kingdom; Rueil-Malmaison, Strasbourg, France)
| |
The six minutes walk distance of Japanese COPD patients
T. Kobayashi, M. Kato, Y. Izuhara, Y. Koshimo, K. Miura, M. Kawashima (Japan)
| |
Prevalence of comorbidities in patients with COPD using the Medprax database in cardiology ambulatory care
M. Hubatsch, P. Kikeli, Z. Preg, M. Laszlo, A. Bocicor, L. Ene, M. German Sallo (Tirgu Mures, Romania)
| |
Coexistence of cardiovascular diseases in patients with COPD
M. Grabicki, I. Brodnicka, H. Batura-Gabryel, B. Brajer, B. Kuznar-Kaminska (Wolica, Poland)
| |